Literature DB >> 2127341

Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide.

F R Burns1, C A Paterson, R D Gray, J T Wells.   

Abstract

Pseudomonas aeruginosa elastase is a zinc metalloproteinase which is released during P. aeruginosa infections. Pseudomonas keratitis, which occurs following contact lens-induced corneal trauma, can lead to rapid, liquefactive necrosis of the cornea. This destruction has been attributed to the release of both host-derived enzymes and the bacterial products P. aeruginosa elastase, alkaline protease, exotoxin A, and lipopolysaccharide endotoxin. A synthetic metalloproteinase inhibitor, HSCH2 (DL)CH[CH2CH(CH3)2]CO-Phe-Ala-NH2, which we previously showed to be a potent inhibitor of corneal collagenase and alkali-induced corneal ulceration, was tested as a potential inhibitor of P. aeruginosa elastase. Inhibition constants (Kis) for the resolved diastereomers were determined with the chromogenic substrate furylacryloyl-glycyl-L-leucyl-L-alanine. One isomer had a Ki of 0.3 microM, while the other had a Ki of 0.4 microM. The more potent diastereomer was evaluated in vivo in experimentally induced Pseudomonas keratitis in rabbits. Following inoculation of one cornea of each rabbit, topical treatment with a 1 mM solution of the inhibitor significantly delayed the onset of corneal melting and perforation, as compared with the results for the control and gentamicin-treated groups. This protective effect suggests that the inhibitor may have a therapeutic application by delaying the progression of corneal destruction in Pseudomonas keratitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127341      PMCID: PMC172000          DOI: 10.1128/AAC.34.11.2065

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  A spectrophotometric assay for neutral protease.

Authors:  J Feder
Journal:  Biochem Biophys Res Commun       Date:  1968-07-26       Impact factor: 3.575

2.  Inhibition by phosphoramidon of Pseudomonas aeruginosa elastase injected intracorneally in rabbit eyes.

Authors:  E Kessler; A Spierer
Journal:  Curr Eye Res       Date:  1984-08       Impact factor: 2.424

3.  Relationship between proteases and descemetocele formation in experimental Pseudomonas keratitis.

Authors:  S S Twining; S D Davis; R A Hyndiuk
Journal:  Curr Eye Res       Date:  1986-07       Impact factor: 2.424

4.  Growth of Pseudomonas aeruginosa and secretion of protease in the presence of the protease inhibitors.

Authors:  E Kessler; M Safrin
Journal:  Metab Pediatr Syst Ophthalmol       Date:  1982

5.  Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases.

Authors:  A S Kreger; D M Lyerly; L D Hazlett; R S Berk
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-06       Impact factor: 4.799

6.  Pseudomonas corneal ulcer with extended-wear soft contact lenses for myopia.

Authors:  G Hassman; J Sugar
Journal:  Arch Ophthalmol       Date:  1983-10

7.  The effect of 2-mercaptoacetyl-L-phenylalanyl-L-leucine, a specific inhibitor of Pseudomonas aeruginosa elastase, on experimental Pseudomonas keratitis in rabbit eyes.

Authors:  A Spierer; E Kessler
Journal:  Curr Eye Res       Date:  1984-04       Impact factor: 2.424

8.  In vitro inhibition of Pseudomonas aeruginosa elastase by metal-chelating peptide derivatives.

Authors:  E Kessler; M Israel; N Landshman; A Chechick; S Blumberg
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  Specific inhibition of Pseudomonas aeruginosa elastase injected intracorneally in rabbit eyes.

Authors:  E Kessler; A Spierer; S Blumberg
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-08       Impact factor: 4.799

10.  Age-related susceptibility of mice to ocular challenge with Pseudomonas aeruginosa exotoxin A.

Authors:  R S Berk; B H Iglewski; L D Hazlett
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.609

View more
  8 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.

Authors:  George R A Cathcart; Derek Quinn; Brett Greer; Pat Harriott; John F Lynas; Brendan F Gilmore; Brian Walker
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

3.  A drug-repositioning screening identifies pentetic acid as a potential therapeutic agent for suppressing the elastase-mediated virulence of Pseudomonas aeruginosa.

Authors:  Mia Gi; Junhui Jeong; Keehoon Lee; Kang-Mu Lee; Masanori Toyofuku; Dong Eun Yong; Sang Sun Yoon; Jae Young Choi
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

4.  Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor.

Authors:  Mary E Marquart; Joseph J Dajcs; Armando R Caballero; Brett A Thibodeaux; Richard J O'Callaghan
Journal:  Med Microbiol Immunol       Date:  2003-11-20       Impact factor: 3.402

5.  Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors.

Authors:  Cansu Kaya; Isabell Walter; Samir Yahiaoui; Asfandyar Sikandar; Alaa Alhayek; Jelena Konstantinović; Andreas M Kany; Jörg Haupenthal; Jesko Köhnke; Rolf W Hartmann; Anna K H Hirsch
Journal:  Angew Chem Int Ed Engl       Date:  2021-12-13       Impact factor: 16.823

6.  Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa.

Authors:  Cansu Kaya; Isabell Walter; Alaa Alhayek; Roya Shafiei; Gwenaëlle Jézéquel; Anastasia Andreas; Jelena Konstantinović; Esther Schönauer; Asfandyar Sikandar; Jörg Haupenthal; Rolf Müller; Hans Brandstetter; Rolf W Hartmann; Anna K H Hirsch
Journal:  ACS Infect Dis       Date:  2022-04-22       Impact factor: 5.578

Review 7.  The Structures and Binding Modes of Small-Molecule Inhibitors of Pseudomonas aeruginosa Elastase LasB.

Authors:  Virgyl Camberlein; Gwenaëlle Jézéquel; Jörg Haupenthal; Anna K H Hirsch
Journal:  Antibiotics (Basel)       Date:  2022-08-04

8.  Persistence of Innate Immune Pathways in Late Stage Human Bacterial and Fungal Keratitis: Results from a Comparative Transcriptome Analysis.

Authors:  Jaya D Chidambaram; Shichina Kannambath; Palepu Srikanthi; Manisha Shah; Prajna Lalitha; Shanmugam Elakkiya; Julien Bauer; Namperumalsamy V Prajna; Martin J Holland; Matthew J Burton
Journal:  Front Cell Infect Microbiol       Date:  2017-05-18       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.